Skip to main content

Published locations for Multicenter trial backs pirfenidone for unclassifiable interstitial lung disease

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Multicenter trial backs pirfenidone for unclassifiable interstitial lung disease

User login

  • Reset your password
  • /content/multicenter-trial-backs-pirfenidone-unclassifiable-interstitial-lung-disease
  • /internalmedicinenews/article/209256/pulmonology/multicenter-trial-backs-pirfenidone-unclassifiable
  • /rheumatologynews/article/209256/pulmonology/multicenter-trial-backs-pirfenidone-unclassifiable
  • /pulmonary-health-hub/article/209256/pulmonology/multicenter-trial-backs-pirfenidone-unclassifiable
  • /rheumatology/article/209256/pulmonology/multicenter-trial-backs-pirfenidone-unclassifiable
  • /internalmedicine/article/209256/pulmonology/multicenter-trial-backs-pirfenidone-unclassifiable
  • /chestphysician/article/209256/pulmonology/multicenter-trial-backs-pirfenidone-unclassifiable